Market Tracker

01/16 5:15pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

35.79
Delayed Data
As of Jan 16
 -0.26 / -0.72%
Today’s Change
15.15
Today|||52-Week Range
37.30
+4.21%
Year-to-Date

Today’s Trading

Previous close36.05
Today’s open36.31
Day’s range35.77 - 36.31
Volume1,073,954
Average volume (3 months)850,451
Market cap$2.5B
Data as of 4:00pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)-0.64%
Earnings growth (next 5 years)+9.30%
Revenue growth (last year)+2.33%
P/E ratio24.0
Price/Sales2.30
Price/Book3.17

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...-0.02-0.02%
NEOGNeogen Corp-0.20-0.34%
IMMUImmunomedics Inc-1.04-6.30%
QDELQuidel Corp+0.42+0.91%
Data as of 4:00pm ET, 01/16/2018

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)$0.24
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts